European equities traded in the US as American depositary receipts were tracking slightly higher Tuesday morning, rising 0.18% to 1,549.94 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical companies DBV Technologies (DBVT) and semiconductor company Sequans Communications (SQNS), which rose 6.2% and 4% respectively. They were followed by pharmaceutical company Ascendis Pharma (ASND) and biopharmaceutical company Genfit (GNFT), which were up 3.4% and 3% respectively.

The decliners from continental Europe were led by oil and gas company TotalEnergies (TTE) and biopharmaceutical company Cellectis (CLLS), which fell 2.2% and 2.1% respectively. They were followed by petroleum refiner Equinor (EQNR) and oil and gas company Eni (E), which were down 1.7% and 1.6% respectively.

From the UK and Ireland, the gainers were led by pharmaceutical company GSK (GSK) and biotech firm Autolus Therapeutics (AUTL), which increased 4.4% and 3.5% respectively. They were followed by pharmaceutical company AstraZeneca (AZN) and utilities company National Grid (NGG), which advanced 1.6% and 1.2% respectively.

The decliners from the UK and Ireland were led by pharmaceutical company Silence Therapeutics (SLN) and biotech firm Trinity Biotech (TRIB), which dropped 4.4% and 1.9% respectively. They were followed by oil and gas company Shell (SHEL) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which lost 1.8% and 1.6% respectively.